# Evaluation of the Safety and Preliminary Efficacy of Neuroinduced Mesenchymal Stem Cells and Exosome Therapy in Patients With Spinocerebellar Palsy

> **NCT07467733** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **Biocells Medical** · enrollment: 90 (estimated)

## Conditions studied

- Spinocerebellar Ataxia - All Sub-types

## Interventions

- **DRUG:** Intrathecal infusion
- **DRUG:** Intranasal infusion

## Key facts

- **NCT ID:** NCT07467733
- **Lead sponsor:** Biocells Medical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2028-06-01
- **Final completion:** 2029-06-01
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2026-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07467733

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07467733, "Evaluation of the Safety and Preliminary Efficacy of Neuroinduced Mesenchymal Stem Cells and Exosome Therapy in Patients With Spinocerebellar Palsy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07467733. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*